Type I collagen peptides and nitric oxide releasing electrospun silk fibroin scaffold: A multifunctional approach for the treatment of ischemic chronic wounds

• Published in: Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2019-03, Vol.175, p.636-643
• Main Authors: Ramadass, Satiesh Kumar, Nazir, Lone Saquib, Thangam, Ramar, Perumal, Ramesh Kannan, Manjubala, I., Madhan, Balaraman, Seetharaman, Shanmuganathan
• Format: Article
• Language: English
• Subjects: Cell proliferation; Collagen; Diabetic foot ulcer; Nanofibrous dressings; Nitric oxide; Silk fibroin
• ISSN: 0927-7765; 1873-4367
• DOI: 10.1016/j.colsurfb.2018.12.025

[Display omitted] •Electrospun SF-PVA nanofibrous scaffold functionalized with collagen peptide and GSNO for wound healing application.•Type I collagen peptides and GSNO is combined to promote tissue regeneration and vasodilation.•CP-GSNO-SF-PVA nanofibers exhibits excellent biocompatibility and antibacterial activity. Biomimetic nanofibrous scaffolds targeting multiple dysfunctional processes provide a multi-pronged strategy to restore functions and regenerate the damaged tissue. This study investigates a strategy of combining a regenerative component, Type I collagen Peptide (CP), along with a nitric oxide donor, S-Nitrosoglutathione (GSNO), in the form of nanofibrous scaffold to address the non-healing diabetic ulcer. Silk Fibroin-Polyvinyl alcohol (SF-PVA) nanofibrous scaffold is used as a carrier for delivering functional moieties. The developed nanofibrous electrospun mats (SF-PVA, CP-SF-PVA, and CP-GSNO-SF-PVA) showed continuous, bead-less and randomly oriented fibers with highly porous morphology. The in vitro biocompatibility was assessed by MTT assay, DAPI-Rhodamine 123 and FITC-Phalloidin imaging studies. CP-GSNO-SF-PVA nanofibrous scaffold showed a high degree of cell attachment, spreading of F-actin with viable cell morphology and appreciable inter-cellular connection. Thus the study showed that the proliferation of fibroblast cells are mainly facilitated by the presence of collagen peptide in the nanofibrous matrix. Griess assay demonstrated immediate release of NO for a day from the developed multifunctional scaffold. These results demonstrate the in vitro efficacy of CP-GSNO and indicate the opportunity of CP-GSNO-SF-PVA nanofibrous scaffold for the treatment of ischemic non-healing ulcers.